ORI Capital
Asia, Hong Kong Island, Hong Kong, Wan Chai'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
ORI Fund is a venture capital fund that invests in innovative companies with disruptive technologies in the global healthcare industry.
Investor Profile
ORI Capital has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 67% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Health Care, Biotechnology, Health Diagnostics.
Stage Focus
- Series B (44%)
- Series C (22%)
- Series D (11%)
- Series E (11%)
- Series A (11%)
Country Focus
- United States (78%)
- United Kingdom (22%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Health Care
- Biotechnology
- Health Diagnostics
- Oncology
- Medical Device
- Medical
- Therapeutics
- Life Science
- Manufacturing
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
